Erin Davis 6/18/26 Erin Davis 6/18/26

Beyond the Genome: Five Emerging Leaders in Epigenetics Diagnostics

Read More

Erin Davis 4/1/26 Erin Davis 4/1/26

How 3D genomic testing from Fox Chase Cancer Center could change the way cancer is diagnosed

Read More

Erin Davis 3/5/26 Erin Davis 3/5/26

Hi-C Mapping Reveals Hidden "Enhancer-Hijacking" in Lymphoid Malignancies

Read More

Erin Davis 1/12/26 Erin Davis 1/12/26

How A New 3D Genomics Test Is Transforming Cancer Diagnosis and Treatment

Read More

Erin Davis 1/8/26 Erin Davis 1/8/26

Fox Chase Cancer Center, Arima Genomics Partner to Implement 3D DNA Analysis in Cancer Dx

Read More

Erin Davis 11/7/25 Erin Davis 11/7/25

Arima Genomics Aims to Replace Some FISH-Based Cancer Tests With Hi-C Sequencing Assays

Read More

Erin Davis 9/5/25 Erin Davis 9/5/25

Arima Genomics’ CEO Sets Sight On Replacing Standard Testing With 3D Genomics Lymphoma Assay

Read More

Erin Davis 7/2/25 Erin Davis 7/2/25

Arima Genomics’ New CEO Strategizes Commercial Growth Push

Read More

Erin Davis 3/21/23 Erin Davis 3/21/23

3D Genomics and targeted cancer therapies

Read More

Erin Davis 3/15/23 Erin Davis 3/15/23

3D Genomics Solves Cancer Case Where Sequencing Came Up Short: Anthony Schmitt, Arima Genomics

Read More

Erin Davis 12/1/22 Erin Davis 12/1/22

Identifying New Therapeutic Targets for Cancer With 3D Genomics

Read More

Erin Davis 10/31/22 Erin Davis 10/31/22

3D genomics reveals targets for aggressive childhood cancers

Read More

Erin Davis 10/13/22 Erin Davis 10/13/22

3D Genome Profiling Can Unlock Undiagnosable Cancers

Read More